Regeneron Pharmaceuticals REGN
NASDAQ REGN
$790.74 -5.60 (-0.70%)
At close: Oct 16, 2026 · 4:00 PM EDT

Regeneron Pharmaceuticals (REGN) Accumulated Expenses (2017 - 2026)

Updated

Regeneron Pharmaceuticals (REGN) recorded Accumulated Expenses of $2.97 billion in Q2 2026, up 20.5% from $2.46 billion a year earlier and up 8.9% from the prior quarter.

Analysis

Regeneron Pharmaceuticals (REGN) Accumulated Expenses (2017 - 2026) Analysis & Trends

At the end of FY2025, Regeneron Pharmaceuticals reported Accumulated Expenses of $2.88 billion, up 13.8% from FY2024.

  • Annual Accumulated Expenses has increased for three straight years, with a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
  • Across earlier years, Accumulated Expenses came in at $2.53 billion in FY2024 (+7.2%), $2.36 billion in FY2023 (+13.7%), $2.07 billion in FY2022 (-6.0%) and $2.21 billion in FY2021 (+34.2%).
  • Quarterly Accumulated Expenses has ranged from $1.8 billion in Q3 2022 to $2.98 billion in Q3 2025 over the past five years.
  • On a year-over-year basis, Accumulated Expenses has increased for five consecutive quarters, with growth averaging 9.3% over the last eight quarters.
  • Peak year-over-year performance for Accumulated Expenses in the last five years was growth of 58.2% in Q3 2021, against a decline of 12.8% in Q3 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.72 billion (Q1 2026), $2.88 billion (Q4 2025) and $2.98 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn
10 Regeneron Pharmaceuticals 81.27 Bn 47.47 Bn 3.71 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.97 Bn
Mar 31, 2026 2.72 Bn
Dec 31, 2025 2.88 Bn
Sep 30, 2025 2.98 Bn
Jun 30, 2025 2.46 Bn
Mar 31, 2025 2.24 Bn
Dec 31, 2024 2.53 Bn
Sep 30, 2024 2.54 Bn
Jun 30, 2024 2.36 Bn
Mar 31, 2024 2.39 Bn
Dec 31, 2023 2.36 Bn
Sep 30, 2023 2.64 Bn
Jun 30, 2023 2.18 Bn
Mar 31, 2023 2.07 Bn
Dec 31, 2022 2.07 Bn
Sep 30, 2022 1.80 Bn
Jun 30, 2022 1.93 Bn
Mar 31, 2022 2.05 Bn
Dec 31, 2021 2.21 Bn
Sep 30, 2021 2.06 Bn
API Access

Regeneron Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=REGN&period=max&api_key=YOUR_API_KEY